Abstract

ORX750, an oral selective Orexin Receptor 2 agonist, promotes wakefulness and reduces cataplexy in the orexin/ataxin-3 mouse

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call